SARS-Co V-2 spike protein

GPTKB entity

Statements (61)
Predicate Object
gptkbp:instance_of gptkb:protein
gptkbp:can_elicit T-cell responses
gptkbp:components viral envelope
recombinant proteins
gptkbp:composed_of S1 and S2 subunits
gptkbp:function facilitates entry of the virus into host cells
gptkbp:has_a_focus_on epidemiological studies
public health research
therapeutic research
molecular studies
gptkbp:has_role viral fusion with host cell membrane
https://www.w3.org/2000/01/rdf-schema#label SARS-Co V-2 spike protein
gptkbp:is_a_subject_of clinical trials
biomedical research
genetic sequencing studies
gptkbp:is_analyzed_in cryogenic electron microscopy
gptkbp:is_associated_with variant strains
immune evasion
vaccine breakthrough infections
immune response variability
gptkbp:is_essential_for vaccine efficacy
viral infectivity
gptkbp:is_expressed_in viral replication
infected cells
gptkbp:is_involved_in immune response
antigen presentation
cell signaling pathways
pathogen recognition
viral pathogenesis
viral entry mechanisms
host immune evasion
viral assembly
viral shedding
viral load determination
gptkbp:is_linked_to long COVID symptoms
disease severity
transmissibility rates
viral fitness.
gptkbp:is_recognized_by neutralizing antibodies
gptkbp:is_studied_for antiviral drug development
vaccine development
therapeutic antibodies
vaccine safety
public health strategies
vaccine formulation
gptkbp:is_studied_in structural biology
gptkbp:is_targeted_at COVID-19 vaccines
gptkbp:is_used_in diagnostic tests
gptkbp:knockouts ACE2 receptor
gptkbp:location on the surface of the virus
gptkbp:modifications glycosylation
gptkbp:occurs_in mutations
gptkbp:targets therapeutic interventions
monoclonal antibodies
vaccine design
broadly neutralizing antibodies
vaccine boosters
gptkbp:trigger_type cytokine release
gptkbp:was_a_factor_in transmission dynamics
gptkbp:bfsParent gptkb:Cure_Vac_CVn_Co_V
gptkbp:bfsLayer 5